GlassScriptPhysician profile
Motasem Refaat
NPI 1780976902
$94,594.65
in general payments reported to CMS, 2019-2025
18 companies · $32K in 2025
The $32K reported for 2025 was more than what 88% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $2,475 · 2021: $15K · 2022: $16K · 2023: $13K · 2024: $545 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Travel and Lodging: $6,417 · Food and Beverage: $4,379 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,524.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Travel and Lodging | $6,417.14 |
| Food and Beverage | $4,379.11 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $26,334.77 | 2023-2025 | Lcp, Na, Va-Lcp |
| Synthes Gmbh | $21,237.96 | 2019-2025 | |
| Biocomposites INC | $19,290.16 | 2019-2024 | Stimulan |
| Synthes USA Products LLC | $11,273.33 | 2022 | |
| Arthrex, INC. | $7,952.73 | 2023-2025 | Distal Extremities Implants Trauma Mini Fragment |
| Depuy Synthes Sales INC. | $2,224.29 | 2019-2025 | Na, Tfn-Advance, Motoband |
| Stryker Corporation | $2,023.48 | 2019-2023 | Axsos, Variax, Gamma |
| Lightbody Medical Technologies INC | $1,862.48 | 2024-2025 | |
| Smith+Nephew, INC. | $1,114.57 | 2019-2021 | |
| Paragon 28, INC. | $612.35 | 2021 | |
| Si-Bone, INC. | $181.04 | 2021-2025 | |
| Nuvasive Specialized Orthopedics, INC. | $144.92 | 2019 | |
| Skeletal Dynamics INC | $132.24 | 2019-2020 | |
| Osteocentric Technologies, INC. | $115.13 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $53.63 | 2022-2023 | Seglentis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cornerstone Medical Associates, INC. | $25.29 | 2023 | |
| Pfizer INC. | $16.28 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$145,731.89 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Motasem Refaat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.